Clinical Trial Update: Open Label Trial of Immunotherapy for Advanced Liver Cancer [Phase 2]

View source ↗

Summary

Open-label Phase 2 trial update of an immunotherapy for advanced liver cancer, with conditions including hepatocellular carcinoma and liver cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cirrhosis

Drugs mentioned

• Immunitor LLC

Snippet

Sponsor: Immunitor LLC | Conditions: HCC, Liver Cirrhosis | Phase 2 | Status: UNKNOWN